Big Gain For Oruka Therapeutics, Inc.
Fri, Mar 13, 2026 at 07:29 PM
Oruka Therapeutics, Inc. (ORKA:NASDAQ) jumped higher at $40, representing a gain of 25%. On Fri, Mar 13, 2026, ORKA:NASDAQ hit a New 2-Week High of $40. The stock appeared on our News Catalysts scanner on Thu, Mar 12, 2026 at 05:47 PM in the 'INVESTOR UPDATE' category. From Fri, Feb 27, 2026, the stock recorded 50.00% Up Days and 63.64% Green Days
About Oruka Therapeutics, Inc. (ORKA:NASDAQ)
ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 125%
- bioAffinity Technologies, Inc. (BIAF:NASDAQ), 98.13%
- Firefly Neuroscience, Inc. (AIFF:NASDAQ), 58.05%
- Silvaco Group, Inc. (SVCO:NASDAQ), 52.42%
- Elong Power Holding Limited (ELPW:NASDAQ), 43.73%
- Polaryx Therapeutics Inc. (PLYX:NASDAQ), 36.77%
- F45 Training Holdings Inc. (FXLV:NYSE), 33.33%
- iSpecimen Inc. (ISPC:NASDAQ), 26.96%
- Oruka Therapeutics, Inc. (ORKA:NASDAQ), 25.04%
- Commercial Vehicle Group, Inc. (CVGI:NASDAQ), 24.46%